Euro
USD
British Pound
NULL
Product Description
Nicotinamide mononucleotide (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. NMN also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation. NMN is used for studying binding motifs within RNA aptamers and ribozyme activation processes involving β-nicotinamide mononucleotide (β-NMN)-activated RNA fragments.
Nicotinamide mononucleotide (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. NMN also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation
Biovision | 2733 | β-Nicotinamide mononucleotide DataSheet
Alternate Name/Synonyms: β-NMN, β-Nicotinamide ribose monophosphate, NMN, Nicotinamide ribotide, Nicotinamide-1-ium-1-β-D-ribofuranoside 5′-phosphate
Appearance: White lyophilzed solid
Formulation: N/A
CAS Number: 1094-61-7
Structure Available?: Y
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₁H₁₅N₂O₈P
Molecular Weight: 334.22
Cell-Permeable?: No
Purity: ≥98% by HPLC
Solubilities: H₂O (50 mg/ml)
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: Enhancer of hepatic insulin sensitivity
MDL Number: MFCD00038748
PubChem CID: 14180
SMILES: C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)[O-])O)O)C(=O)N
InChi: InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/m1/s1
InChi Key: DAYLJWODMCOQEW-TURQNECASA-N
